Eli Lilly (LLY) closed the latest trading day at $822.51, indicating a -0.27% change from the previous session's end. The stock's performance was ahead of the S&P 500's daily loss of 1.07%. On the ...

Parnassus Core Equity Fund sees Eli Lilly And Co. (NYSE:LLY) as a strong long-term investment due to its GLP-1 franchise and ...

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

Lilly Pulitzer and Disney just teamed up for a new collection that’s as colorful and fun as you’d expect. It includes a ...

The company was previously housed at the BioScience Center, an Uptown incubator focused on bioscience and life-science ...

Miley Cyrus was perfect choice for the double role of Miley Stewart and Hannah Montana, but other celebs who auditioned for ...

As a drugmaker depending heavily on sales of both branded and non-branded products, Teva has said that it is uniquely affected by how medicines are selected for the Medicare drug price negotiation | ...

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of ...

More consistent accumulation demonstrated in bloodstream over a one-week duration with once-daily DehydraTECH-tirzepatide oral capsules as compared to once-weekly injection of Zepbound®As previously a ...

The finance sector is strongly represented in this year's attendees. HSBC Group Chief Executive Georges Elhedery is on the ...

The vote clears the way for a proposed multibillion-dollar expansion of the former Nexus Pharmaceuticals facility.